• Title/Summary/Keyword: Gastric $H^{+}/K^{+}$-ATPase inhibitors

Search Result 7, Processing Time 0.022 seconds

Furo[3,2-h]quinoline Derivatives as a Gastric H+/K+-ATPase Inhibitors

  • Kang, Seung-Kyu;Cho, Sung-Yun;Kim, Sung-Soo;Cheon, Hyae-Gyeong;Choi, Joong-Kwon;Yum, Eul-Kgun
    • Bulletin of the Korean Chemical Society
    • /
    • v.23 no.3
    • /
    • pp.454-458
    • /
    • 2002
  • Furo[3,2-h]quinoline derivatives were synthesized as a gastric $H^+$/$K^+$-ATPase inhibitors. The oxycyclization of 7 and 8-positions in quinoline potentiated the inhibitory activity, while no significant changes in biological activity were observed by the variation of substituents in furan ring. The several furo[3,2-h]quinoline derivatives were worthy of in vivo investigation for their anti-secretory and anti-ulcer activity.

Synthesis and SAR of Benzimidazole Derivatives Containing Oxycyclic Pyridine as a Gastric $H^+/K^+$-ATPase Inhibitors

  • Jo, Seong Un;Gang, Seong Gyu;Kim, Seong Su;Jeon, Hae Gyeong;Choe, Jong Gwon;Yeom, Eul Geon
    • Bulletin of the Korean Chemical Society
    • /
    • v.22 no.11
    • /
    • pp.1217-1223
    • /
    • 2001
  • A series of benzimidazole derivatives containing oxycyclic pyridine was prepared and evaluated for their gastric H+ /K+ -ATPase inhibitory activity. Several of the synthesized compound exhibited potent antisecretion in pylorus-ligated rats when administered intradoudenally. Their inhibitory activities were equivalent or comparable to omeprazole.

Potassium-competitive acid blocker-associated gastric mucosal lesions

  • Kimitoshi Kubo;Noriko Kimura;Mototsugu Kato
    • Clinical Endoscopy
    • /
    • v.57 no.4
    • /
    • pp.417-423
    • /
    • 2024
  • Since the introduction of vonoprazan, a potassium-competitive acid blocker (P-CAB), it has been demonstrated to reversibly inhibit gastric acid secretion by engaging in potassium-competitive ionic binding to H+/K+-ATPase. In contrast, proton pump inhibitors (PPIs) achieve H+/K+-ATPase inhibition through covalent binding to cysteine residues of the proton pump. Reported cases have indicated an emerging trend of P-CAB-related gastropathies, similar to those associated with PPIs, as well as unique gastropathies specific to P-CAB use, such as the identification of web-like mucus. Pathologically, parietal cell profusions, which show a positively correlated with hypergastrinemia, have a higher incidence in P-CAB users compared to PPI users. Thus, this review aims to summarize the endoscopic and pathological findings reported to date concerning P-CAB-related gastric mucosal lesions. Additionally, it seeks to discuss the differences between the PPIs and P-CABs in terms of the formation and frequency of associated gastropathies. This review highlights the evident differences in the mechanism of action and potency of acid inhibition between P-CABs and PPIs, notably contributing to differences in the formation and frequency of associated gastropathies. It emphasizes the necessity to distinguish between P-CAB-related and PPI-related gastropathies in the clinical setting.

Inhibitory mechanism of a newly synthesised proton pump inhibitor, YJA20379-8

  • Sang K. Sohn;Man S. Chang;Young K. Chung;Kim, Kyu B.;Tae W. Woo;Kim, Sung K.;Park, Wahn S.
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1997.04a
    • /
    • pp.100-100
    • /
    • 1997
  • To treat peptic ulcer diseases, many potent proton pump inhibitors have been developed for suppressing the gastric acid secretion in clinical patients. However, most of these agents have common irreversible mechanisms against H$\^$+/, K$\^$+/-ATPase which might be the cause of hypergastrinemia and ECL cell hyperplasia. Therefore, the development of new reversible inhibitors is prompted. In this study, we investigated the inhibitory mechanism of a newly synthesized proton pump inhibitor, YJA20379-8 using lyophilized hog gastric microsomes. YJA20379-8 inhibited K$\^$+/-stimulated H$\^$+/K$\^$+/-ATPase activity uncompetitively with respect to K$\^$+/, and in the other hand, showed competitive inhibitory pattern with ATP, respectively. From these data, we suggest that YJA20379-8 may be a proton pump inhibitor with a new inhibitory mechanism.

  • PDF

Synthesis of Pyrazoloquinolines as Gastric $H^+/K^+$-ATPase Inhibitors

  • G. D. Kalayanov;Kang, S. K.;Cheon, H.G.;Lee, S.G.;Yum, E. K.;Kim, S. S.;Choi, J.-K.
    • Bulletin of the Korean Chemical Society
    • /
    • v.19 no.6
    • /
    • pp.667-671
    • /
    • 1998
  • A series of 1-aryl-lH-pyrazolo[4,3-c]quinolines and 2-aryl-2H-pyrazolo[4,3-c]quinolines are prepared by reacting 3-acyl-4-chloroquinolines in ethanol or 3-acyl-4(lH)-quinolone in acetic acid with appropriate hydrazines as possible anti-ulcer agents. A regiospecific synthesis of 1-aryl-lH-pyrazolo[4,3-c]quinolines is also achieved. The central pyridine ring could be easily reduced by catalytic hydrogenation.

Effect of Radish on HeLa Cell Vacuolation Induced by Helicobacter pylori Cytotoxin (HeLa세포에서 Helicobacter pylori 독소에 의한 공포형성에 미치는 무의 효과)

  • Shon, Yun-Hee;Surh, Jung-Ill;Chung, Yu-Jin;Park, In-Kyung;Kim, Ho-Chang;Hwang, Cheorl-Weon;Kim, Cheorl-Ho;Nam, Kyung-Soo
    • Korean Journal of Pharmacognosy
    • /
    • v.35 no.3 s.138
    • /
    • pp.250-254
    • /
    • 2004
  • Helicobacter pylori (H. pyroli) infection it associated with type B gastritis, peptic uler disease, and gastric cancer. The vacuolation of cells induced by H. pylori is thought to be essential for the initiation and maintenance of gastric infection. The roles of H. pylori cytotoxin, urease, and ammonia in the vacuolation of HeLa cells were determined. H. pylori toxin induced vacuolation of HeLa cells. Korean and Japanese radishes significantly prevented the vacuolation of HeLa cells induced by H. pylori toxin. The urease activity in vacuolated cells was also decreased with Korean and Japanese radishes. H. Pylori toxin-induced vacuolation was inhibited by vacuolar type ATPase inhibitors (bafilomycin and N-ethylmaleimide). However, further investigation is required to determine the mechanisms of radish for the inhibition of vacuole formation of eukaryotic cells in response to the H. pylori toxin.